Go to:
Logótipo
Você está em: Start > Publications > View > Comprimidos anti-anémicos – pré-formulação com promotores de absorção
Publication

Comprimidos anti-anémicos – pré-formulação com promotores de absorção

Title
Comprimidos anti-anémicos – pré-formulação com promotores de absorção
Type
Article in National Scientific Journal
Year
1995
Authors
Paulo Lobão
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
ISSN: 0484-811X
Indexing
Publicação em ISI Web of Science ISI Web of Science
Scientific classification
FOS: Medical and Health sciences > Other medical sciences
CORDIS: Health sciences > Pharmacological sciences > Pharmacy
Other information
Language: Portuguese
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs. (2012)
Another Publication in an International Scientific Journal
Almeida, H; Maria Helena Amaral; Paulo Lobão; Lobo, JM
Nanoparticles in ocular drug delivery systems for topical administration: Promises and challenges (2015)
Another Publication in an International Scientific Journal
Almeida, H; Maria Helena Amaral; Paulo Lobão; Frigerio, C; Lobo, JMS
In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations (2014)
Another Publication in an International Scientific Journal
Hugo Almeida; Maria Helena Amaral; Paulo Lobao; Jose Manuel S Sousa Lobo
Drugs obtained by biotechnology processing (2011)
Another Publication in an International Scientific Journal
Hugo Almeida; Maria Helena Amaral; Paulo Lobao
Multiparticulate sustained release system containing ibuprofen. (2010)
Summary of Presentation in an International Conference
Paulo Lobão

See all (48)

Of the same scientific areas

Multiparticulate sustained release system containing ibuprofen. (2010)
Summary of Presentation in an International Conference
Paulo Lobão
Influence of Granulometry in the Release of a Soluble Drug from Carnauba Wax Matrix Tablets (2009)
Summary of Presentation in an International Conference
Paulo Lobão
Formulation and in-vitro evaluation of captopril-Carbopol 971P extended release matrix tablets : influence of concentration of polymer on dissolution parameters (2001)
Summary of Presentation in an International Conference
Paulo Lobão
Formulation and in-vitro evaluation of adhesive bilayer matrix tablets containing captopril (2001)
Summary of Presentation in an International Conference
Paulo Lobão
FORMULATION AND IN VITRO EVALUATION OF ADHESIVE BILAYER MATRIX TABLETS CONTAINING CAPTOPRIL (2008)
Summary of Presentation in an International Conference
Paulo Lobão

See all (23)

Of the same journal

Transdermal drug delivery systems [SISTEMAS DE LIBERTACAO TRANSDERMICA] (1993)
Another Publication in an International Scientific Journal
Costa, P; Ferreira, DC; Sousa Lobo, JM
The treatment of obesity should be direct. Which therapeutic strategies [Tratar a obesidade e um dever e um direito. Que estrategias e terapias praticar?] (2000)
Another Publication in an International Scientific Journal
Ferreira, MA; Pinho, OMC; Oliveira, MBPP; Ferreira, IMPL
Potential cardiotoxic agents [Farmacos como potenciais agentes cardiotoxicos] (1999)
Another Publication in an International Scientific Journal
Remiao, F; Bastos, MDL
Fundamental aspects of gels [Geles -Aspectos fundamentais] (2000)
Another Publication in an International Scientific Journal
Almeida, I; Bahia, MF
Drug treatment of peptic ulcer [O TRATAMENTO MEDICO DA ULCERA PEPTICA] (1995)
Another Publication in an International Scientific Journal
Guimaraes, S; Albino Teixeira, A

See all (83)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Arquitectura da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-11-09 at 06:53:33 | Acceptable Use Policy | Data Protection Policy | Complaint Portal